Menthol in Cigarettes, Tobacco Products; Request for Comments; Extension of Comment Period, 55671 [2013-22015]
Download as PDF
Federal Register / Vol. 78, No. 176 / Wednesday, September 11, 2013 / Proposed Rules
13. Section 762.2 is amended by
revising paragraph (b)(13) to read as
follows:
■
§ 762.2
Records to be retained.
*
*
*
*
*
(b) * * *
(13) § 744.15(b), UVL statement as
well as any logs or records created for
multiple shipments;
*
*
*
*
*
Dated: September 3, 2013.
Kevin J. Wolf,
Assistant Secretary for Export
Administration.
[FR Doc. 2013–21996 Filed 9–10–13; 8:45 am]
BILLING CODE 3510–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1140
[Docket No. FDA–2013–N–0521]
Menthol in Cigarettes, Tobacco
Products; Request for Comments;
Extension of Comment Period
AGENCY:
Food and Drug Administration,
HHS.
Advance notice of proposed
rulemaking; extension of comment
period.
ACTION:
The Food and Drug
Administration (FDA) is extending the
comment period for the advance notice
of proposed rulemaking (ANPRM) that
appeared in the Federal Register of July
24, 2013 (78 FR 44484). In the ANPRM,
FDA requested comments, including
comments on FDA’s preliminary
evaluation, and data, research, or other
information that may inform regulatory
actions that FDA might take with
respect to menthol in cigarettes. The
Agency is taking this action in response
to requests for an extension to allow
interested persons additional time to
submit comments.
DATES: FDA is extending the comment
period on the ANPRM. Submit either
electronic or written comments by
November 22, 2013.
ADDRESSES: You may submit comments,
identified by Docket No. FDA–2013–N–
0521, by any of the following methods:
tkelley on DSK3SPTVN1PROD with PROPOSALS
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
VerDate Mar<15>2010
16:39 Sep 10, 2013
Jkt 229001
Written Submissions
Submit written submissions in the
following ways:
• Mail/Hand delivery/Courier (for
paper or CD–ROM submissions):
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
Instructions: All submissions received
must include the Agency name and
Docket No. FDA–2013–N–0521 for this
rulemaking. All comments received may
be posted without change to https://
www.regulations.gov, including any
personal information provided. For
additional information on submitting
comments, see the ‘‘Comments’’ heading
of the SUPPLEMENTARY INFORMATION
section of this document.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Lauren Berkowitz or Annette L.
Marthaler, Center for Tobacco Products,
Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850–
3229, 877–287–1373, CTPRegulations@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of July 24,
2013 (78 FR 44484), FDA published an
ANPRM with a 60-day comment period
to request comments on FDA’s
preliminary evaluation, and data,
research, or other information that may
inform regulatory actions FDA might
take with respect to menthol in
cigarettes.
The Agency has received comments
requesting a 60-day extension of the
comment period for the ANPRM. These
comments convey concern that the
current 60-day comment period does
not allow sufficient time to develop
meaningful or thoughtful responses to
questions raised in the ANPRM. FDA
has also received comments opposing
an extension of the current comment
period on the grounds that ample time
has been given to comment on the
issues raised in the ANPRM.
FDA has considered the requests and
is extending the comment period for the
ANPRM for 60 days, until November 22,
2013. The Agency believes that a 60-day
extension allows adequate time for
interested persons to submit comments
PO 00000
Frm 00015
Fmt 4702
Sfmt 4702
55671
without significantly delaying any
potential regulatory action on these
important issues.
II. Request for Comments
Interested persons may submit either
electronic comments regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
Dated: September 4, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–22015 Filed 9–10–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF VETERANS
AFFAIRS
38 CFR Part 17
RIN 2900–AO78
Hospital Care and Medical Services for
Camp Lejeune Veterans
Department of Veterans Affairs.
Proposed rule.
AGENCY:
ACTION:
The Department of Veterans
Affairs (VA) proposes to amend its
regulations to implement a statutory
mandate that VA provide health care to
certain veterans who served at Camp
Lejeune, North Carolina, for at least 30
days during the period beginning on
January 1, 1957, and ending on
December 31, 1987. The law requires
VA to furnish hospital care and medical
services for these veterans for certain
illnesses and conditions that may be
attributed to exposure to toxins in the
water system at Camp Lejeune. This
proposed rule does not implement the
statutory provision requiring VA to
provide health care to these veterans’
family members; regulations applicable
to such family members are currently in
development and will be promulgated
through a separate notice.
DATES: Comments must be received on
or before October 11, 2013.
ADDRESSES: Written comments may be
submitted through https://
www.regulations.gov; by mail or handdelivery to Director, Regulations
Management (02REG), Department of
Veterans Affairs, 810 Vermont Avenue
NW., Room 1068, Washington, DC
SUMMARY:
E:\FR\FM\11SEP1.SGM
11SEP1
Agencies
[Federal Register Volume 78, Number 176 (Wednesday, September 11, 2013)]
[Proposed Rules]
[Page 55671]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-22015]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1140
[Docket No. FDA-2013-N-0521]
Menthol in Cigarettes, Tobacco Products; Request for Comments;
Extension of Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Advance notice of proposed rulemaking; extension of comment
period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is extending the
comment period for the advance notice of proposed rulemaking (ANPRM)
that appeared in the Federal Register of July 24, 2013 (78 FR 44484).
In the ANPRM, FDA requested comments, including comments on FDA's
preliminary evaluation, and data, research, or other information that
may inform regulatory actions that FDA might take with respect to
menthol in cigarettes. The Agency is taking this action in response to
requests for an extension to allow interested persons additional time
to submit comments.
DATES: FDA is extending the comment period on the ANPRM. Submit either
electronic or written comments by November 22, 2013.
ADDRESSES: You may submit comments, identified by Docket No. FDA-2013-
N-0521, by any of the following methods:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Written Submissions
Submit written submissions in the following ways:
Mail/Hand delivery/Courier (for paper or CD-ROM
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Instructions: All submissions received must include the Agency name
and Docket No. FDA-2013-N-0521 for this rulemaking. All comments
received may be posted without change to https://www.regulations.gov,
including any personal information provided. For additional information
on submitting comments, see the ``Comments'' heading of the
SUPPLEMENTARY INFORMATION section of this document.
Docket: For access to the docket to read background documents or
comments received, go to https://www.regulations.gov and insert the
docket number, found in brackets in the heading of this document, into
the ``Search'' box and follow the prompts and/or go to the Division of
Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Lauren Berkowitz or Annette L.
Marthaler, Center for Tobacco Products, Food and Drug Administration,
9200 Corporate Blvd., Rockville, MD 20850-3229, 877-287-1373,
CTPRegulations@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of July 24, 2013 (78 FR 44484), FDA
published an ANPRM with a 60-day comment period to request comments on
FDA's preliminary evaluation, and data, research, or other information
that may inform regulatory actions FDA might take with respect to
menthol in cigarettes.
The Agency has received comments requesting a 60-day extension of
the comment period for the ANPRM. These comments convey concern that
the current 60-day comment period does not allow sufficient time to
develop meaningful or thoughtful responses to questions raised in the
ANPRM. FDA has also received comments opposing an extension of the
current comment period on the grounds that ample time has been given to
comment on the issues raised in the ANPRM.
FDA has considered the requests and is extending the comment period
for the ANPRM for 60 days, until November 22, 2013. The Agency believes
that a 60-day extension allows adequate time for interested persons to
submit comments without significantly delaying any potential regulatory
action on these important issues.
II. Request for Comments
Interested persons may submit either electronic comments regarding
this document to https://www.regulations.gov or written comments to the
Division of Dockets Management (see ADDRESSES). It is only necessary to
send one set of comments. Identify comments with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday, and will be posted to the docket at https://www.regulations.gov.
Dated: September 4, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-22015 Filed 9-10-13; 8:45 am]
BILLING CODE 4160-01-P